Anson Funds Management LP 13D/13G Filings for TransCode Therapeutics, Inc. (RNAZ)

Anson Funds Management LP 13D and 13G filings for TransCode Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
5:16 pm
Purchase
2024-12-3113GTransCode Therapeutics, Inc.
RNAZ
Anson Funds Management LP113,479
9.900%
113,479increase
(New Position)
Filing